XLH UK supports those with X-linked hypophosphataemia and related disorders.

NICE does not currently recommend burosumab for eligible adults – act now!

Latest news and views

NICE guidance rejects burosumab for adults

NICE guidance rejects burosumab for adults

NICE has released draft guidance on the Health Technology Assessment of burosumab for adults in England. Their evaluation and XLH UK's response is explained in the press release below, along with a five step Call to Action! for all members of the XLH community. ...

read more
XLH UK Newsletter – October 2023

XLH UK Newsletter – October 2023

Welcome to XLH’s Navigator newsletter for Autumn 2023. Hear about our recent Connect meeting and a visit to the Welsh Parliament. Don’t miss the next newsletter and subscribe here: https://xlhuk.org/registration-form/ You can view it here:...

read more
XLH UK visit the Welsh Parliament

XLH UK visit the Welsh Parliament

At a recent Senedd roundtable event, Oliver Gardiner, representing XLH UK, and Claire Lewis, a Welsh XLH patient, were joined by Mike Hedges MS. Mike Hedges, who chairs the Senedd Cross Party Group on Rare Diseases, brought invaluable expertise and leadership to the...

read more

Would you like to receive our newsletter?